Vigabatrin in the treatment of epilepsy: a long-term follow-up study.

Por Tartara, A, Manni, R, Galimberti, C A, Mumford, J P, Iudice, A, Perucca, E
Publicado em 1989

Effects of vigabatrin on evoked potentials in epileptic patients

Por Cosi, V., Callieco, R., Galimberti, C. A., Manni, R., Tartara, A., Mumford, J., Perucca, E.
Publicado em 1989

The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid.

Por Tartara, A, Galimberti, C A, Manni, R, Morini, R, Limido, G, Gatti, G, Bartoli, A, Strada, G, Perucca, E
Publicado em 1993

Differential effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients

Por Tartara, A., Galimberti, C.A., Manni, R., Parietti, L., Zucca, C., Baasch, H., Caresia, L., Mück, W., Barzaghi, N., Gatti, G., Perucca, E.
Publicado em 1991

Risk Factors for Neurodegeneration in Idiopathic REM sleep Behavior Disorder: A Multicenter Study

Por Postuma, RB, Iranzo, A, Hogl, B, Arnulf, I, Ferini-Strambi, L, Manni, R, Miyamoto, T., Oertel, W, Dauvilliers, Y, Ju, Y, Puligheddu, M, Sonka, K, Pelletier, A, Santamaria, J, Frauscher, B, Leu-Semenescu, S, Zucconi, M, Terzaghi, M, Miyamoto, M., Unger, MM, Carlander, B, Fantini, ML, Montplaisir, JY
Publicado no Ann Neurol (2015)

Environmental risk factors for REM sleep behavior disorder: A multicenter case-control study

Por Postuma, R.B., Montplaisir, J.Y., Pelletier, A., Dauvilliers, Y., Oertel, W., Iranzo, A., Ferini-Strambi, L., Arnulf, I., Hogl, B., Manni, R., Miyamoto, T., Mayer, G., Stiasny-Kolster, K., Puligheddu, M., Ju, Y., Jennum, P., Sonka, K., Santamaria, J., Fantini, M.L., Zucconi, M., Leu-Semenescu, S., Frauscher, B., Terzaghi, M., Miyamoto, M., Unger, M.M., Cochen De Cock, V., Wolfson, C.
Publicado em 2012